skip to main content

    Updated Visitor Guidelines

 

MENU

 

Wednesday, September 27 Schedule of U-M Presentations at ASTRO

 

10 - 10:45am

Reshma Jagsi, University of Michigan, ASTRO Guidelines Highlight: Review of the Recommendations of the WBI Guidelines
Location: Ballroom 20

11:40am-12pm

Martha Matuszak, University of Michigan: SPECT-CT Guided Lung and Liver Sparing
Location: 26 A/B

Tuesday, September 26 Schedule of U-M Presentations at ASTRO

 

1 - 2pm

Latifa Bazzi, U-M Radiation Oncology: Predictors of Long-Term Survival Among Locally Advanced Non–small Cell Lung Cancer Patients Undergoing Definitive Radiation Therapy [Poster Q & A]
Location: Poster Hall
Abstract: 2860

Monday, September 25 Schedule of U-M Presentations at ASTRO

University of Michigan Radiation Oncologists are attending ASTRO. Issam El Naqa, Robert Dess, Yi Luo, Yue Cao and Payal Soni will be presenting today.

See Pink Go Blue

With more than 250,000 women and men being diagnosed and over 40,000 dying from breast cancer a year it's time to SEE PINK GO BLUE!

See Pink Go Blue for Breast Cancer

DONATE NOW!
Click on the image or TEXT: Text: SPGB to 50555 to give $10 to U-M Comprehensive Cancer Center.

Reading cancer's chemical clues

A nanoparticle-assisted optical imaging technique could one day enable doctors to read those clues in real time, providing a non-invasive precision medicine approach that could match treatment to individual tumors.

Sunday, September 24 Schedule of U-M Presentations at ASTRO

1:15 - 2:45pm

Dawn Owen, U-M Radiation Oncology: Utility of 4DMRI for Liver Radiation Planning [e-poster]
Abstract #165
Location: 5B

Kyle Cuneo, U-M Radiation Oncology: Monitoring Circulating Tumor Cells during Chemoradiation Therapy for Locally Advanced Pancreatic Cancer [Poster Q & A]
Abstract #1019
Location: Poster Hall

New Research Grants

graphic of a researcher looking through a microscope

 

Several new research grants greater than $100,000 were awarded to University of Michigan Rogel Cancer Center researchers in November. Highlights include: 

NCI Awards

Focal Therapy for Prostate Cancer

Just as we are understanding the individual cancer cells and pathways, we are also incorporating more individualized treatment options for prostate cancer. Newer options that potentially offer minimal side effects is referred to as focal therapy. We are able to be more accurate in determining the tumor location through a more precise prostate biopsy with the use of MRI allowing us to treat smaller areas of the prostate.

Pages